Molybdenum Disulfide Nanocomposites for Cancer Diagnosis and Therapeutics: Biosensors, Bioimaging, and Phototherapy
Advanced Healthcare Materials · 2025
DOI: 10.1002/adhm.202500655 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Fatemeh Sasanipoor und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, College of Chemistry and Chemical Engineering, China University of Petroleum (East China), Qingdao, 266580, China. Hauptthemen laut MEDLINE: Molybdenum, Disulfides, Nanocomposites, Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 286 Literaturangaben. Gefördert von: Natural Science Foundation of Shandong Province, Fundamental Research Funds for the Central Universities, Graduate Education Reform Project.
Abstract (Originalsprache)
Molybdenum disulfide (MoS₂) nanomaterials have attracted significant interest in cancer diagnosis and therapy due to their unique physicochemical properties. Due to its extensive surface area and adaptable structure, MoS₂ may engage with pharmaceuticals and biomolecules via covalent and non‐covalent interactions. This versatility enhances the sensitivity of identifying specific biomarkers, colloidal stability, and tumor‐targeting capabilities. In the near‐infrared (NIR) spectrum, MoS₂ exhibits strong optical absorption and efficient photothermal conversion, making it suitable for NIR‐driven phototherapy and regulated medication release. Functionalized MoS₂ nanocomposites react differently to the tumor microenvironment, which improves treatment effectiveness by increasing drug accumulation at cancer sites and decreasing off‐target effects on healthy tissues. Recent developments in MoS₂‐based nanocomposites for cancer detection and treatment are reviewed in this study, with particular attention paid to their uses in photothermal therapy, photodynamic therapy, biosensing, and bioimaging. Additionally, it looks at the difficulties and potential applications of MoS₂ nanocomposites in cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, College of Chemistry and Chemical Engineering, China University of Petroleum (East China), Qingdao, 266580, China.
ORCID-Profile: Zhiqing Zhang
Förderung
- Natural Science Foundation of Shandong Province
- Fundamental Research Funds for the Central Universities
- Graduate Education Reform Project
- Fundamental Research Funds for Central Universities of the Central South University
Zitieren
APA
Sasanipoor, F., & Zhang, Z. (2025). Molybdenum Disulfide Nanocomposites for Cancer Diagnosis and Therapeutics: Biosensors, Bioimaging, and Phototherapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202500655
Vancouver
Sasanipoor F, Zhang Z. Molybdenum Disulfide Nanocomposites for Cancer Diagnosis and Therapeutics: Biosensors, Bioimaging, and Phototherapy. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202500655
BibTeX
@article{Sasanipoor2025,
author = {Sasanipoor, Fatemeh and Zhang, Zhiqing},
title = {Molybdenum Disulfide Nanocomposites for Cancer Diagnosis and Therapeutics: Biosensors, Bioimaging, and Phototherapy},
journal = {Advanced Healthcare Materials},
year = {2025},
doi = {10.1002/adhm.202500655}
}
EUVIMED